Jack Wetzels

Nurse practitioner care improves renal outcome in patients with CKD.

Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.

Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.

Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.

TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.

Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.

Urinary biomarkers after donor nephrectomy.

Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.

Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.

Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.

Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up.

Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Therapy: Maintenance of steroid-free remission in nephrotic syndrome.

Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.

Estimation of total kidney volume in autosomal dominant polycystic kidney disease.

Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B-cells.

Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.

Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology.

Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.

Kidney Weight in Living and Postmortal Kidney Donation.

Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.

Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.

Renal Handling of Circulating and Renal-Synthesized Hepcidin and Its Protective Effects against Hemoglobin-Mediated Kidney Injury.

Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test Study.

Central arteriovenous anastomosis and hypertension.

1,25-Vitamin D3 Deficiency Induces Albuminuria.

Quality of chronic kidney disease management in primary care: a retrospective study.

Abdominal aortic calcification in patients with CKD.

Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?

Kidney Dysfunction Increases Mortality and Incident Events after Young Stroke: The FUTURE Study.

Pharmacological treatment of primary membranous nephropathy in 2016.

Drug therapy management in patients with renal impairment: how to use creatinine-based formulas in clinical practice.

Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.

Uremic Solutes in Chronic Kidney Disease and Their Role in Progression.

Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.

The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.

Glomerular disease in 2016: New advances in the treatment of glomerular disease.

Web-based consultation between general practitioners and nephrologists: a cluster randomized controlled trial.

Adherence to chronic kidney disease guidelines in primary care patients is associated with comorbidity.

Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).

Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.

Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.

Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.

Urinary Excretion of α-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant Recipients.

Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.

Use of the Furosemide Fludrocortisone Test to Clinically Assess Distal Tubular Acidification.

Disposition and clinical implications of protein-bound uremic toxins.

A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with Mutations.

Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.

Renal physiology: Prostaglandins in thiazide-induced hyponatraemia: do they hold water?

Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.

Reference values of renal tubular function tests are dependent on age and kidney function.

CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.

Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.

Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.

Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers.

General practitioners' perspectives on management of early-stage chronic kidney disease: a focus group study.

The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.

What Patients with Mild-to-Moderate Kidney Disease Know, Think, and Feel about Their Disease: An In-Depth Interview Study.

Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy.

Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling.

The authors reply.

Urine Acidification After Ammonium Chloride.

The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting.

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Antibodies Against M-Type Phospholipase Receptor and Prediction of Outcome in Membranous Nephropathy: We are Not There Yet.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab.

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.

Placental passage of eculizumab and complement blockade in a newborn.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

The bias between different albumin assays may affect clinical decision-making.

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models.

The authors reply.

Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome.

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.

Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing.

Complement inhibitors are not useful in secondary hemolytic uremic syndromes.

The multifaceted role of iron in renal health and disease.

The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.

Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature.

The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases.

The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment.

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.

Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis.

Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury?

Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease.

Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis.

Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant-Based Meta-analysis.

Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group.